• No results found

Non-Convulsive Status Epilepticus (NCSE) in ICU

N/A
N/A
Protected

Academic year: 2020

Share "Non-Convulsive Status Epilepticus (NCSE) in ICU"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

Figure

Table 1 Status Epilepticus Management in ICU1
Table 2 Drugs dosing used in refractory status epilepticus in ICU1

References

Related documents

While the increase in mean daily microbial protein production between the treatments was unexpected given the available literature on drivers for DMI (Chapter 2) and the data at

Table 7.1 The average clay mineralogy of samples from the weathered and unweathered zone from representative mudstone boreholes in Oju and Obi and the

Checkpoint inhibitors T umor T reatment Line Phase Primar y endpoint NCT Number PD-L1 inhibitor/CTLA-4 inhibitor Esophageal cancer Dur valumab ± tr emelimumab + chemotherap y – I/II

e Journal of the Canadian Historical Association / Revue de la Société Historique du Canada ( JCHA / RSCH ) has been published continuously for almost a century.. roughout

The very existence of the macula, however, is a partial fix for the “backward” arrangement of retinal layers with the nerve and blood vessels between the receptors and the direction

With respect to the difference in serum IL-18 levels among different genotypes within the same group, null significant results were found in both case and control groups,

Conclusion: In the present study, a significant difference was observed between patient and control groups in serum amylin concentrations, which were considerably higher in